Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody. (Q39433325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Sejin Son

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ji Young Jang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Myung Hee Kwon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ki Dong Park

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

3 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

932-942

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22139535%20AND%20SRC:MED&resulttype=core&format=json

Monoclonal anti-DNA antibodies: structure, specificity, and biology

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Anti-DNA antibodies: aspects of structure and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

An RNA-hydrolyzing recombinant antibody exhibits an antiviral activity against classical swine fever virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Practical considerations in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

New advances in microsphere-based single-dose vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Dual-drug delivery system based on hydrogel/micelle composites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Release of human serum albumin from poly(lactide-co-glycolide) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Biodegradable nanoparticles for cytosolic delivery of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Polysaccharides-based nanoparticles as drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0633-0

Crystal structure of single-domain VL of an anti-DNA binding antibody 3D8 scFv and its active site revealed by complex structures of a small molecule and metals

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22139535

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22139535

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22139535